• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

Lumify already at 20% market share! #1 position in just a few wks













I question this company's accounting practices. Just because you put a junk product on a shelf somewhere doesn't mean that someone is actually going to buy it.

Fair point, I think the actual retail POS sales have been pretty good though. All Bausch has to do is follow the old skin-care Cerave formula; make sure optho's are recommending the product and customers will pick it up from Walgreens / CVS / Lenscrafters. No different than derms recommending Cerave moisturizer.